🚀
Enjoy a 7-Day Free Trial Thru Sep 25, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Strategies Created by Users
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
All Topics
General Discussions
Investment Ideas
Strategies
Article Comments
Books
Feedback
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Medical Diagnostics & Research
Guardant Health Inc (FRA:5GH)
News
Guardant Health Inc
FRA
:5GH (USA) Â
€ 22.89
(-0.3%)
Sep 16
P/E:
At Loss
P/B:
0
Market Cap:
€ 2.82B
($ 3.13B)
Enterprise V:
€ 3.09B
($ 3.44B)
Volume:
150.00
Avg Vol (2M):
256.00
Warning! GuruFocus detected 5 Severe warning signs with 5GH.
Try a 7-Day Free Trial
to check it out.
Trade In:
Volume:
150.00
Market Cap €:
2.82B
Market Cap $:
3.13B
PE Ratio:
At Loss
Avg Vol (2M):
256.00
Enterprise Value €:
3.09B
Enterprise Value $:
3.44B
PB Ratio:
0
Alerts
Website
Sources
Stock PDF
Dataset
Financial Download
Manual of Stocks™
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Guardant Health Inc (FRA:5GH) Stock News, Headlines & Updates
Guardant Health Inc Stock News from GuruFocus
Total 21
1
Sep 16, 2024
Guardant Health Inc (GH) Stock Price Down 9.01% on Sep 16
GuruFocus Research
•
10:01am
Sep 13, 2024
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
Business Wire
•
2:00am
Sep 11, 2024
Guardant Health Inc (GH) Shares Down 2.87% on Sep 11
GuruFocus Research
•
11:05am
Sep 10, 2024
Guardant Health Inc (GH) Trading 7.15% Higher on Sep 10
GuruFocus Research
•
2:11pm
Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
Business Wire
•
8:00am
Aug 27, 2024
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Business Wire
•
4:00pm
Aug 22, 2024
Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening
Business Wire
•
5:00pm
Aug 08, 2024
Guardant Health to Participate in Upcoming Investor Conferences
Business Wire
•
4:00pm
Guardant Health Inc (GH) Q2 2024 Earnings Call Transcript Highlights: Robust Revenue Growth Amid Financial Challenges
GuruFocus Research
•
3:01am
Q2 2024 Guardant Health Inc Earnings Call Transcript
GuruFocus Research
•
2:30am
Aug 07, 2024
Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
Business Wire
•
4:00pm
Guardant Health Inc (GH) Q2 2024 Earnings: Revenue Surpasses Estimates at $177.2 Million, GAAP EPS Net Loss of $0.84
GuruFocus Research
•
3:42pm
Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
Business Wire
•
8:00am
Aug 01, 2024
Guardant Health's FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
Business Wire
•
8:00am
Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
Business Wire
•
8:00am
Jul 29, 2024
What's Driving Guardant Health Inc's Surprising 90% Stock Rally?
GuruFocus Research
•
9:11am
Guardant Health's Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
Business Wire
•
6:00am
Jul 24, 2024
Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
Business Wire
•
4:00pm
Jul 23, 2024
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
Business Wire
•
8:00am
Jul 18, 2024
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
Business Wire
•
5:00pm
Jul 05, 2024
Baillie Gifford Reduces Stake in Guardant Health Inc.
GuruFocus Research
•
1:01pm
Total 21
1
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news